Charles River Laboratories | CRL - Srodki Pieniężne I Ekwiwalent

Cena Akcji
159.17
Dzienna Zmiana
3.14 2.01%
Miesięcznie
-13.87%
Rocznie
17.38%
Q2 Prognozy TE
147.82




Srodki Pieniężne I Ekwiwalent Zmiana Data
Agilent USD 1.76B 31M 2025-12
Align Technology USD 1.06B 35.07M 2026-03
Bio-Rad Laboratories USD 507.2M 22.6M 2026-03
Bruker USD 133.4M 165.4M 2026-03
Cardinal Health USD 3.94B 1.16B 2026-03
Charles River Laboratories USD 191.83M 21.94M 2026-03
Cigna USD 7.04B 636M 2026-03
Concord Medical Services Hldg CNY 243.38M 85.1M 2023-06
CVS Health USD 9.54B 1.09B 2026-03
Danaher USD 5.7B 1.09B 2026-03
Dentsply International USD 190M 136M 2026-03
Elevance Health USD 9.66B 166M 2026-03
Humana USD 4.95B 751M 2026-03
Illumina USD 1.42B 368M 2025-12
Incyte USD 4.02B 435.22M 2026-03
Intrexon USD 9.34M 1.77M 2024-06
IQVIA Holdings USD 1.95B 33M 2026-03
Laboratory Of America USD 981.1M 448.8M 2026-03
Lakefront Biotherapeutics EUR 66.8M 21.06M 2026-03
Lonza CHF 719M 188M 2025-12
McKesson USD 3.98B 1.02B 2026-03
Merck EUR 2.33B 77M 2025-12
Mettler Toledo International USD 66.89M 2.18M 2025-12
Novartis USD 6.88B 4.56B 2026-03
Pfizer USD 1.7B 561M 2026-03
Quest Diagnostics USD 393M 27M 2026-03
Revvity USD 860.32M 59.54M 2026-03
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
United Therapeutics USD 1.28B 277.4M 2026-03
UnitedHealth USD 31.23B 3.11B 2026-03
Veradigm USD 492.6M 7.57M 2022-09
Waters USD 462M 125.83M 2026-03
West Pharmaceutical Services USD 521.4M 269.9M 2026-03